You are here

What ignites gut inflammation?

Description 
Project synopsis: Inflammatory bowel disease (IBD) is a common, complex and chronic disease that can cause abdominal pain, bleeding and diarrhoea. Advanced therapies often visibly heal the bowel and achieve periods of remission, however despite this, many patients eventually relapse. This clinical pattern suggests that “invisible” drivers of IBD persist, even during periods of remission. This project will use advanced spatial technologies to identify these invisible drivers of disease. The over-arching goal of this work is to help achieve deeper remission and improve the quality-of-life for patients with IBD. Project in more detail: Our team recently discovered a new form of inflammation that arises in patients with IBD who are in remission (Pang & Al-Ani et al., 2026 Science). This project involved collecting over 900 intestinal biopsies from 80 patients with or without IBD and performing in-depth molecular analyses on these biopsies. This project will pair markers of nascent inflammation with advanced spatial ‘omic technologies to identify the upstream drivers of gut damage in patients with IBD. Specifically, this project will answer the fundamental question: What feature distinguishes an inflamed niche from uninflamed tissue a few cells away in the same IBD patient? And is this distinguishing pro-inflammatory feature sufficient to activate immune cells? Key techniques: • laser-capture microdissection • mass spectrometry-based proteomics • metatranscriptomics • advanced bioinformatic analyses • human cell culture Supervisory team: • Dr Andre Samson – Head of the Gut Inflammation Laboratory at the Centre for Inflammatory Diseases (Monash University) • Dr Maria Tanzer – Laboratory Head at the Walter and Eliza Hall Institute of Medical Research, specialising in mass spectrometry-based proteomics • Dr Michael Christie – Molecular and Anatomical Pathologist and Deputy Director of Pathology at the Royal Melbourne Hospital Related work from the team: • Pang & Al-Ani et al., (2026) Science • Chiou et al., (2026) Cell Death & Differentiation • Chiou & Al-Ani et al., (2024) EMBO Molecular Medicine
Essential criteria: 
Minimum entry requirements can be found here: https://www.monash.edu/admissions/entry-requirements/minimum
Keywords 
Inflammation, Inflammatory Bowel Disease, IBD, ulcerative colitis, Crohn's disease, spatial biology, proteomics, transcriptomics, gastroenterology
School 
School of Clinical Sciences at Monash Health / Hudson Institute of Medical Research
Available options 
PhD/Doctorate
Masters by research
Honours
BMedSc(Hons)
Joint PhD/Exchange Program
Time commitment 
Full-time
Part-time
Top-up scholarship funding available 
No
Physical location 
Monash Health Translation Precinct (Monash Medical Centre)
Co-supervisors 
Dr 
Maria Tanzer
(External)
Dr 
Michael Christie
(External)

Want to apply for this project? Submit an Expression of Interest by clicking on Contact the researcher.